OpportunityTitle: Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse, National Institutes of Health, encourages Exploratory / Developmental Research Project Grant (R21) applications from institutions/ organizations that propose to develop non-invasive (including but not limited to urine, sweat or oral fluids) or minimally invasive (such as fingerstick), methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs). The announcement has two main aims. The first aim is to encourage the development of devices / techniques that will improve estimations of a subjects consumption of an abused drug (i.e. both quantity and frequency of consumption) during an outpatient clinical trial. Such a system would allow the objective assessment of whether a medication reduces drug abuse, even if abstinence is not achieved. Proposed solutions should be able to assess systemic drug levels and be safe, portable, affordable and simple enough for subjects to take multiple samples at home and return them to the clinic for batch analysis.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;